Skip to Main Content
Table 1.

Patient data

No.AgeTumor-node-metastasis stageTumor size (cm) max. diameterSUV tumorSUV LNStaining pattern IHC αvβ3*
50 pT1 pN2b cM0 G2 0.2 n.d. 4.00 Tumor vessels in lymph node metastasis positive; ++ 
35 pT3 pN0 cM0 G2 2.0 3.80 — Tumor vessels positive; + 
59 pT1 pN0 cM0 G1 1.4 3.10 — Tumor vessels positive; + 
42 mcT3 cN0 cM0 G3 3.0 5.80 — Tumor vessels and cells positive; ++ 
   1.8 3.57 —  
61 pT1 pN1 cM0 G2 1.0 2.38 n.d. Tumor vessels positive; + 
59 pT2 pN1 cM0 G2 4.5 5.26 n.d. Tumor vessels positive; ++ 
59 pT2 pN0 cM0 G2 4.0 3.25 — Tumor vessels positive; ++ 
52 mpT1 pN0 cM0 G1 0.1/0.3 n.d. —  
63 cT3 cN2c cM0 G3 2.0 2.75 n.d.  
10 55 cT3 cN2c cM1 G3 3.0 2.20 2.05  
11 58 cT3 cN1 cM0 G3 3.2 2.30 n.d.  
No.AgeTumor-node-metastasis stageTumor size (cm) max. diameterSUV tumorSUV LNStaining pattern IHC αvβ3*
50 pT1 pN2b cM0 G2 0.2 n.d. 4.00 Tumor vessels in lymph node metastasis positive; ++ 
35 pT3 pN0 cM0 G2 2.0 3.80 — Tumor vessels positive; + 
59 pT1 pN0 cM0 G1 1.4 3.10 — Tumor vessels positive; + 
42 mcT3 cN0 cM0 G3 3.0 5.80 — Tumor vessels and cells positive; ++ 
   1.8 3.57 —  
61 pT1 pN1 cM0 G2 1.0 2.38 n.d. Tumor vessels positive; + 
59 pT2 pN1 cM0 G2 4.5 5.26 n.d. Tumor vessels positive; ++ 
59 pT2 pN0 cM0 G2 4.0 3.25 — Tumor vessels positive; ++ 
52 mpT1 pN0 cM0 G1 0.1/0.3 n.d. —  
63 cT3 cN2c cM0 G3 2.0 2.75 n.d.  
10 55 cT3 cN2c cM1 G3 3.0 2.20 2.05  
11 58 cT3 cN1 cM0 G3 3.2 2.30 n.d.  

Abbreviations: LN, lymph node; IHC, immunohistochemistry; n.d., lesion not depicted by [18F]Galacto-RGD PET.

*

Overall staining intensity: 0, negative; +, weak; ++, moderate; +++, intense staining.

Close Modal

or Create an Account

Close Modal
Close Modal